ArticleMedicina (Kaunas, Lithuania)2022

Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients.

Hana Hadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.